Angela Bellini

Institut Curie

*This is an algorithmically generated author record based on publicly available information.

See Latest Publications

See Most Cited Publications

ORCID Profile

Google Scholar

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Research Subjects

Research Interests

Angela Bellini has a total of 78 co-authors. Here are the top co-authors by number of shared publications:

Alexandra Saint-Charles
Institut Curie 4 INSERM U1330, Childhood Oncology Research Unit (CONCERT) Paris, France
52 shared publications
Gudrun Schleiermacher
Institut Curie, Paris, France
52 shared publications
Jaydutt Bhalshankar
Sorbonne Université, Inserm, CNRS, UMR S 1127, Paris Brain Institute (ICM), Equipe labellisée Ligue Nationale contre le Cancer Paris France
52 shared publications
Olivier Delattre
INSERM U830, Diversity and Plasticity of Childhood Tumors Lab, PSL Research University, SIREDO Oncology Center, Institut Curie Research Center, Paris, France
52 shared publications
Yasmine Iddir
Institut Curie 4 INSERM U1330, Childhood Oncology Research Unit (CONCERT) Paris, France
52 shared publications
John Ciaran Hutchinson
Great Ormond Street Hospital NHS Foundation Trust, London, UK
40 shared publications

Latest Publications

Sort by

Open Access
Website
Google Scholar
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S3 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
by Elizabeth R. Tucker, Irene Jiménez, Lindi Chen, Angela Bellini, Chiara Gorrini, Elizabeth Calton, Qiong Gao, Harvey Che, Evon Poon, Yann Jamin, et al.
Website
Google Scholar
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Figure S3 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
by Elizabeth R. Tucker, Irene Jiménez, Lindi Chen, Angela Bellini, Chiara Gorrini, Elizabeth Calton, Qiong Gao, Harvey Che, Evon Poon, Yann Jamin, et al.
Open Access
Website
Google Scholar
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Data DS1 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
by Elizabeth R. Tucker, Irene Jiménez, Lindi Chen, Angela Bellini, Chiara Gorrini, Elizabeth Calton, Qiong Gao, Harvey Che, Evon Poon, Yann Jamin, et al.
Supplementary methods, supplementary tables, supplementary figure legends
Website
Google Scholar
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Data DS1 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
by Elizabeth R. Tucker, Irene Jiménez, Lindi Chen, Angela Bellini, Chiara Gorrini, Elizabeth Calton, Qiong Gao, Harvey Che, Evon Poon, Yann Jamin, et al.
Supplementary methods, supplementary tables, supplementary figure legends
Open Access
Website
Google Scholar
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S5 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
by Elizabeth R. Tucker, Irene Jiménez, Lindi Chen, Angela Bellini, Chiara Gorrini, Elizabeth Calton, Qiong Gao, Harvey Che, Evon Poon, Yann Jamin, et al.
Website
Google Scholar
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Figure S5 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
by Elizabeth R. Tucker, Irene Jiménez, Lindi Chen, Angela Bellini, Chiara Gorrini, Elizabeth Calton, Qiong Gao, Harvey Che, Evon Poon, Yann Jamin, et al.
Open Access
Website
Google Scholar
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S2 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
by Elizabeth R. Tucker, Irene Jiménez, Lindi Chen, Angela Bellini, Chiara Gorrini, Elizabeth Calton, Qiong Gao, Harvey Che, Evon Poon, Yann Jamin, et al.
Website
Google Scholar
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Figure S2 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
by Elizabeth R. Tucker, Irene Jiménez, Lindi Chen, Angela Bellini, Chiara Gorrini, Elizabeth Calton, Qiong Gao, Harvey Che, Evon Poon, Yann Jamin, et al.
Open Access
Website
Google Scholar
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S6 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
by Elizabeth R. Tucker, Irene Jiménez, Lindi Chen, Angela Bellini, Chiara Gorrini, Elizabeth Calton, Qiong Gao, Harvey Che, Evon Poon, Yann Jamin, et al.
Cell line growth curves and PDX data for idasanutlin combination
Website
Google Scholar
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Figure S6 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
by Elizabeth R. Tucker, Irene Jiménez, Lindi Chen, Angela Bellini, Chiara Gorrini, Elizabeth Calton, Qiong Gao, Harvey Che, Evon Poon, Yann Jamin, et al.
Cell line growth curves and PDX data for idasanutlin combination
Open Access
Website
Google Scholar
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S1 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
by Elizabeth R. Tucker, Irene Jiménez, Lindi Chen, Angela Bellini, Chiara Gorrini, Elizabeth Calton, Qiong Gao, Harvey Che, Evon Poon, Yann Jamin, et al.
Website
Google Scholar
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Figure S1 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
by Elizabeth R. Tucker, Irene Jiménez, Lindi Chen, Angela Bellini, Chiara Gorrini, Elizabeth Calton, Qiong Gao, Harvey Che, Evon Poon, Yann Jamin, et al.
Open Access
Website
Google Scholar
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S4 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
by Elizabeth R. Tucker, Irene Jiménez, Lindi Chen, Angela Bellini, Chiara Gorrini, Elizabeth Calton, Qiong Gao, Harvey Che, Evon Poon, Yann Jamin, et al.
Website
Google Scholar
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Figure S4 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
by Elizabeth R. Tucker, Irene Jiménez, Lindi Chen, Angela Bellini, Chiara Gorrini, Elizabeth Calton, Qiong Gao, Harvey Che, Evon Poon, Yann Jamin, et al.
Open Access
Website
Google Scholar
Cited by 7
- 30 January 2025
- Published by Elsevier in Cancer Letters
ATRX mutations mediate an immunogenic phenotype and macrophage infiltration in neuroblastoma
by Federica Lorenzi, Sina Jostes, Qiong Gao, J. Ciaran Hutchinson, Jennifer Tall, Barbara Martins da Costa, Anisha J. Cooke, Dyanne Rampling, Olumide Ogunbiyi, Karen Barker, et al.
Website
Google Scholar
- 30 January 2025
- Published by Elsevier in Cancer Letters
Open Access
ATRX mutations mediate an immunogenic phenotype and macrophage infiltration in neuroblastoma
by Federica Lorenzi, Sina Jostes, Qiong Gao, J. Ciaran Hutchinson, Jennifer Tall, Barbara Martins da Costa, Anisha J. Cooke, Dyanne Rampling, Olumide Ogunbiyi, Karen Barker, et al.
Cited by 7
Open Access
Website
Google Scholar
- 1 August 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table 4 from Sequential Analysis of cfDNA Reveals Clonal Evolution in Patients with Neuroblastoma Receiving ALK-Targeted Therapy
by Charles Bobin, Yasmine Iddir, Charlotte Butterworth, Julien Masliah-Planchon, Alexandra Saint-Charles, Angela Bellini, Jaydutt Bhalshankar, Gaelle Pierron, Valérie Combaret, Valéry Attignon, et al.
Supplementary Table 4 from Sequential Analysis of cfDNA Reveals Clonal Evolution in Patients with Neuroblastoma Receiving ALK-Targeted Therapy
Website
Google Scholar
- 1 August 2024
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Table 4 from Sequential Analysis of cfDNA Reveals Clonal Evolution in Patients with Neuroblastoma Receiving ALK-Targeted Therapy
by Charles Bobin, Yasmine Iddir, Charlotte Butterworth, Julien Masliah-Planchon, Alexandra Saint-Charles, Angela Bellini, Jaydutt Bhalshankar, Gaelle Pierron, Valérie Combaret, Valéry Attignon, et al.
Supplementary Table 4 from Sequential Analysis of cfDNA Reveals Clonal Evolution in Patients with Neuroblastoma Receiving ALK-Targeted Therapy
Open Access
Website
Google Scholar
- 1 August 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table 1 from Sequential Analysis of cfDNA Reveals Clonal Evolution in Patients with Neuroblastoma Receiving ALK-Targeted Therapy
by Charles Bobin, Yasmine Iddir, Charlotte Butterworth, Julien Masliah-Planchon, Alexandra Saint-Charles, Angela Bellini, Jaydutt Bhalshankar, Gaelle Pierron, Valérie Combaret, Valéry Attignon, et al.
Supplementary Table 1 from Sequential Analysis of cfDNA Reveals Clonal Evolution in Patients with Neuroblastoma Receiving ALK-Targeted Therapy
Website
Google Scholar
- 1 August 2024
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Table 1 from Sequential Analysis of cfDNA Reveals Clonal Evolution in Patients with Neuroblastoma Receiving ALK-Targeted Therapy
by Charles Bobin, Yasmine Iddir, Charlotte Butterworth, Julien Masliah-Planchon, Alexandra Saint-Charles, Angela Bellini, Jaydutt Bhalshankar, Gaelle Pierron, Valérie Combaret, Valéry Attignon, et al.
Supplementary Table 1 from Sequential Analysis of cfDNA Reveals Clonal Evolution in Patients with Neuroblastoma Receiving ALK-Targeted Therapy

Show all